亚洲最大的种植牙企业，韩国上市公司…
Osstem Implant’s audit opinion received ‘appropriate’. The risk of delisting is likely to be avoided
This article is translated by AI company Flitto and Infostock Daily using neural machine translation technology.
Osstem Implant, which has been embroiled in a massive embezzlement case, has avoided the worst delisting crisis due to its “appropriate” audit opinion.
As a result, about 20,000 minority shareholders are relieved from the risk of losing all their investments. However, if the listing is not maintained on the upcoming Fate Day (30), the transaction will still be suspended during the improvement grant period, which will tie the investment.
According to the financial investment industry on the 27th, Osstem Implant will be decided by the Korea Exchange’s Corporate Review Committee on the 30th.
When the delisting is concluded, the final decision will be made to the KOSDAQ Market Committee, but the crisis was avoided when Induk Accounting Corp., an external auditor, submitted its “appropriate” opinion as an audit opinion.
KOSDAQ-listed companies are subject to formal delisting immediately after the substantive review of their listing eligibility is suspended if their audit opinions are inappropriate.
Indeok Accounting Corp., an external auditor of Osstem Plant, requested the appointment of external experts to the company’s internal audit to review whether there were any irregularities similar to whether the largest shareholders and employees were involved in the embezzlement that took place last year.
As a result, as of December 31 last year, Osstem Implant’s financial performance and cash flow were thoroughly audited through forensics in accordance with international accounting standards and judged to be appropriate.
Reporter Lee Ji-sun stockmk2020@infostock.co.kr
以下来自谷歌翻译：
深陷巨额挪用公款案的Osstem Implant，因其“适当”的审计意见，避免了最严重的退市危机。
因此，大约 20,000 名小股东免除了失去所有投资的风险。但是，如果在即将到来的命运日(3月30)不维持上市，在改善补助期间仍将暂停交易，这将与投资挂钩。
据金融投资行业3月27日消息，Osstem Implant将于3月30日由韩国交易所企业审查委员会决定。
当退市结束时，最终决定将交给 KOSDAQ 市场委员会，但当外部审计师 Induk Accounting Corp. 提交其“适当”的意见作为审计意见时，危机得以避免。
在科斯达克上市的公司，如果审计意见不恰当，将在暂停上市资格实质性审查后立即正式退市。
Osstem Plant 的外部审计师 Indeok Accounting Corp. 要求任命外部专家对公司的内部审计进行审查，以审查是否存在与去年发生的大股东和员工是否参与挪用公款类似的违规行为。
因此，截至2021年12月31日，Osstem Implant 的财务业绩和现金流量均按照国际会计准则通过法证进行了彻底审计，并被判断为适当。
版权声明：所有「牙牙在线」的原创文章，转载须联系授权，并在文首/文末注明来源、作者、微信ID，否则我们将向其追究法律责任。部分文章推送时未能与原作者或公众号平台取得联系。若涉及版权问题，敬请原作者联系我们。